eCite Digital Repository

Chronic beta2-adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men

Citation

Hostrup, M and Onslev, J and Jacobson, G and Wilson, R and Bangsbo, J, Chronic beta2-adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men, Journal of Physiology ISSN 0022-3751 (2017) [Refereed Article]


Preview
PDF (Accepted 5th October http://onlinelibrary.wiley.com/doi/10.1113/JP274970/full)
Available from 12 November 2018
3Mb
  

Copyright Statement

Copyright 2017 The Authors. Copyright 2017 The Physiological Society

DOI: doi:10.1113/JP274970

Abstract

Although the effects of training have been studied for decades, data on muscle proteome signature remodelling induced by high intensity training in relation to functional changes in humans remains incomplete. Likewise, β2 -agonists are frequently used to counteract exercise-induced bronchoconstriction, but the effects β2 -agonist treatment on muscle remodelling and adaptations to training are unknown. In a placebo-controlled parallel study, we randomized 21 trained men to four weeks of high intensity training with (HIT + β2 A) or without (HIT) daily inhalation of β2 -agonist (terbutaline, 4 mg d-1 ). Of 486 proteins identified by mass-spectrometry proteomics of muscle biopsies sampled before and after the intervention, 32 and 85 were changing (FDR ≤ 5%) with the intervention in HIT and HIT + β2 A. Proteome signature changes were different in HIT and HIT + β2 A (P = 0.005), wherein β2 -agonist caused a repression of 25 proteins in HIT + β2 A compared to HIT, and an upregulation of 7 proteins compared to HIT. β2 -agonist repressed or even downregulated training-induced enrichment of pathways related to oxidative phosphorylation and glycogen metabolism, but upregulated pathways related to histone trimethylation and the nucleosome. Muscle contractile phenotype changed differently in HIT and HIT + β2 A (P ≤ 0.001), with a fast-to-slow twitch transition in HIT and a slow-to-fast twitch transition in HIT + β2 A. β2-agonist attenuated training-induced enhancements in maximal oxygen consumption (P ≤ 0.01) and exercise performance (11.6 vs. 6.1%, P ≤ 0.05) in HIT + β2 A compared to HIT. These findings indicate that daily β2 -agonist treatment attenuates the beneficial effects of high intensity training on exercise performance and oxidative capacity, and causes remodelling of muscle proteome signature towards a fast-twitch phenotype.

Item Details

Item Type:Refereed Article
Keywords:proteomics beta2-agonists
Research Division:Medical and Health Sciences
Research Group:Pharmacology and Pharmaceutical Sciences
Research Field:Pharmaceutical Sciences
Objective Division:Health
Objective Group:Other Health
Objective Field:Health not elsewhere classified
Author:Jacobson, G (Dr Glenn Jacobson)
Author:Wilson, R (Mr Russell Wilson)
ID Code:121676
Year Published:2017
Deposited By:Pharmacy
Deposited On:2017-10-10
Last Modified:2017-11-22
Downloads:0

Repository Staff Only: item control page